Viatris Inc (VTRS)
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Viatris Inc is a Healthcare company with a market capitalization of $19.02B and a dividend yield of 2.99%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $0.59 | $0.50 | +18.0% |
| Q4 2025 | February 26, 2026 | $0.57 | $0.53 | +6.6% |
| Q3 2025 | November 6, 2025 | $0.67 | $0.62 | +8.1% |
| Q2 2025 | August 7, 2025 | $0.62 | $0.56 | +10.7% |
| Q1 2025 | May 8, 2025 | $0.50 | $0.49 | +2.0% |
| Q4 2024 | February 27, 2025 | $0.54 | $0.57 | -5.6% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Viatris Inc's market cap?
As of June 29, 2026, Viatris Inc (VTRS) has a market capitalization of $19.02B.
Does Viatris Inc pay a dividend?
Yes — Viatris Inc pays a dividend yielding 2.99%, an annual payout of $0.48 per share.
What sector is VTRS in?
Viatris Inc is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What was Viatris Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Viatris Inc reported revenue of $14.30B and net income of -$3.51B.
Ask your own questions about VTRS
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.